Pediatric rheumatology

A rare disease with many faces: a multicentre registry of IgG4-related disease in children

Rheumatology (Oxford)Published Multicentre registry study

Authors' conclusion

IgG4-RD has a wide variety of clinical manifestations; however, in children, the most common presentation was orbital involvement. The 2020 RCD criteria had a better performance whereas the 2019 ACR/EULAR classification criteria performed poorly in paediatric patients.

Study context

Population
Children with IgG4-related disease (IgG4-RD) diagnosed by the 2011 comprehensive diagnostic criteria, 13 paediatric rheumatology centres19 females · 16 males
Participants
35 children
Exposure
2019 ACR/EULAR vs 2020 revised comprehensive diagnostic (RCD)
Outcome
Characteristics of paediatric IgG4-RD
Methodological detailsweb-based registry, 13 paediatric rheumatology centres
  • Web-based registry
  • 13 paediatric rheumatology centres

Main finding

As reported in the abstract

Median age at diagnosis (25p-75p 9.9-15.2), years
13.3
Eye involvement
n = 21, 60%
Lymph node involvement
n = 12, 34.3%
Musculoskeletal involvement
n = 12, 34.3%
Neurological involvement
n = 9, 25.7%
Cluster: eye involvement
n = 11, 31.4%
Cluster: eye involvement and neurological findings
n = 15, 42.9%
Cluster: pancreato-hepatobiliary disease and lymph node involvement
n = 9, 25.7%
High serum IgG4 levels (19 out of 28 patients)
67.8%

Observational data: associations, not effects.

Further findings

Sensitivity of classification/diagnostic criteria

Sensitivity

Treatment

All patients except one received corticosteroids; azathioprine the most preferred steroid-sparing agent

Original publication

A rare disease with many faces: a multicentre registry of IgG4-related disease in children. Rheumatology (Oxford). Published 19 September 2024. doi:10.1093/rheumatology/keae497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.